Steroid hormone secretion after stimulation of mineralocorticoid and NMDA receptors and cardiovascular risk in patients with depression (Q92093383)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32313032 AND SRC:MED&resulttype=core&format=json

26 April 2020

title

Steroid hormone secretion after stimulation of mineralocorticoid and NMDA receptors and cardiovascular risk in patients with depression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32313032 AND SRC:MED&resulttype=core&format=json

26 April 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32313032 AND SRC:MED&resulttype=core&format=json

26 April 2020

Christian Otte

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32313032 AND SRC:MED&resulttype=core&format=json

26 April 2020

author name string

Jan Nowacki

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32313032 AND SRC:MED&resulttype=core&format=json

26 April 2020

Michael Kaczmarczyk

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32313032 AND SRC:MED&resulttype=core&format=json

26 April 2020

Woo Ri Chae

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32313032 AND SRC:MED&resulttype=core&format=json

26 April 2020

Paula Salchow

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32313032 AND SRC:MED&resulttype=core&format=json

26 April 2020

Ikram Abu-Tir

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32313032 AND SRC:MED&resulttype=core&format=json

26 April 2020

Dominique Piber

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32313032 AND SRC:MED&resulttype=core&format=json

26 April 2020

Julian Hellmann-Regen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32313032 AND SRC:MED&resulttype=core&format=json

26 April 2020

publication date

20 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32313032 AND SRC:MED&resulttype=core&format=json

26 April 2020

published in

Translational Psychiatry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32313032 AND SRC:MED&resulttype=core&format=json

26 April 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32313032 AND SRC:MED&resulttype=core&format=json

26 April 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32313032 AND SRC:MED&resulttype=core&format=json

26 April 2020

page(s)

109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32313032 AND SRC:MED&resulttype=core&format=json

Major depressive disorder

26 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

The cardiovascular toll of stress

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Stress and corticosterone increase the readily releasable pool of glutamate vesicles in synaptic terminals of prefrontal and frontal cortex.

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Targeting glutamate signalling in depression: progress and prospects

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Depression and cardiovascular disease: Epidemiological evidence on their linking mechanisms

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Heartache and heartbreak--the link between depression and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Depression and coronary heart disease.

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

The brain mineralocorticoid receptor and stress resilience

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

The HPA axis in major depression: classical theories and new developments

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

The role of mineralocorticoid receptor function in treatment-resistant depression

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary-adrenal activity in humans with psychotic major depression.

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Mineralocorticoid receptor function in depressed patients and healthy individuals

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

miRNA Expression Change in Dorsal Root Ganglia After Peripheral Nerve Injury

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Ketamine: A Paradigm Shift for Depression Research and Treatment

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Effect of subanaesthetic ketamine on plasma and saliva cortisol secretion

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Ketamine interactions with biomarkers of stress: a randomized placebo-controlled repeated measures resting-state fMRI and PCASL pilot study in healthy men.

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

A randomized add-on trial of high-dose D-cycloserine for treatment-resistant depression

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

D-Cycloserine in Neuropsychiatric Diseases: A Systematic Review

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

d-Cycloserine, an NMDA Glutamate Receptor Glycine Site Partial Agonist, Induces Acute Increases in Brain Glutamate Plus Glutamine and GABA Comparable to Ketamine

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Depression and cardiovascular disorders

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Metabolites of Glutamate Metabolism Are Associated With Incident Cardiovascular Events in the PREDIMED PREvención con DIeta MEDiterránea (PREDIMED) Trial

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Aldosterone: a forgotten mediator of the relationship between psychological stress and heart disease

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Aldosterone Antagonist Therapy and Mortality in Patients With ST-Segment Elevation Myocardial Infarction Without Heart Failure: A Systematic Review and Meta-analysis

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Increased plasma aldosterone in patients with clinical depression

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Genetic, Molecular and Clinical Determinants for the Involvement of Aldosterone and Its Receptors in Major Depression

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

To live alone and to be depressed, an alarming combination for the renin-angiotensin-aldosterone-system (RAAS).

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Clinical significance of decreased protein expression of dehydroepiandrosterone sulfate in the development of depression: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Central mineralocorticoid receptors and the role of angiotensin II and glutamate in the paraventricular nucleus of rats with angiotensin II-induced hypertension

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

The novel dehydroepiandrosterone (DHEA) derivative BNN27 counteracts behavioural deficits induced by the NMDA receptor antagonist ketamine in rats

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Regional-specific effects of cerebral ischemia/reperfusion and dehydroepiandrosterone on synaptic NMDAR/PSD-95 complex in male Wistar rats.

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

An Inventory for Measuring Depression

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Exploration of the awakening cortisol response in relation to diurnal cortisol secretory activity

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Selective attention to emotional cues and emotion recognition in healthy subjects: the role of mineralocorticoid receptor stimulation

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Depression and cortisol responses to psychological stress: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Comparison of the effects of ketamine and memantine on prolactin and cortisol release in men. a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

The partial NMDA agonist D-cycloserine stimulates LH secretion in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Behavioral and neuroendocrine effects of the partial NMDA agonist D-cycloserine in healthy subjects

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Sleep-dependent declarative memory consolidation--unaffected after blocking NMDA or AMPA receptors but enhanced by NMDA coagonist D-cycloserine

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Enhancement of Psychosocial Treatment With D-Cycloserine: Models, Moderators, and Future Directions

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

The glycine site of NMDA receptors: A target for cognitive enhancement in psychiatric disorders

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Mineralocorticoid receptor function and cognition in health and disease

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Top-down and bottom-up control of stress-coping

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Mineralocorticoid receptor stimulation improves cognitive function and decreases cortisol secretion in depressed patients and healthy individuals

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Why are depressed patients inflamed? A reflection on 20 years of research on depression, glucocorticoid resistance and inflammation

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Cortisol and DHEA in development and psychopathology

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Salivary cortisol in depressed patients versus control persons: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

The Renin-Angiotensin-Aldosterone system in patients with depression compared to controls – a sleep endocrine study

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Aldosterone concentrations in saliva reflect the duration and severity of depressive episode in a sex dependent manner

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Target-based biomarker selection - Mineralocorticoid receptor-related biomarkers and treatment outcome in major depression

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Markers of mineralocorticoid receptor function: changes over time and relationship to response in patients with major depression

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Psychopathological symptoms in patients with primary hyperaldosteronism--possible pathways

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Sub-chronic dietary tryptophan depletion – An animal model of depression with improved face and good construct validity

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Subchronic treatment with aldosterone induces depression-like behaviours and gene expression changes relevant to major depressive disorder

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Morning cortisol as a risk factor for subsequent major depressive disorder in adult women

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Recent life events, cortisol, dehydroepiandrosterone and the onset of major depression in high-risk adolescents.

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Aldosterone Signals the Onset of Depressive Behaviour in a Female Rat Model of Depression along with SSRI Treatment Resistance

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

A review of lifestyle factors that contribute to important pathways associated with major depression: diet, sleep and exercise

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Third-generation Mineralocorticoid Receptor Antagonists: Why Do We Need a Fourth?

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

30 YEARS OF THE MINERALOCORTICOID RECEPTOR: The role of the mineralocorticoid receptor in the vasculature

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Association of diurnal patterns in salivary cortisol with all-cause and cardiovascular mortality: findings from the Whitehall II study

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Urinary Cortisol and Six-Year Risk of All-Cause and Cardiovascular Mortality

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

High evening salivary cortisol is an independent predictor of increased mortality risk in patients with systolic heart failure

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Circulating aldosterone and natriuretic peptides in the general community: relationship to cardiorenal and metabolic disease

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Dehydroepiandrosterone (DHEA) replacement decreases insulin resistance and lowers inflammatory cytokines in aging humans

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

https://api.crossref.org/works/10.1038/S41398-020-0789-7

1 reference

7 January 2021

Nonfasting glucose, ischemic heart disease, and myocardial infarction: a Mendelian randomization study

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Non-fasting blood glucose and risk of incident coronary heart disease in middle-aged general population: the Circulatory Risk in Communities Study (CIRCS).

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

The biological actions of dehydroepiandrosterone involves multiple receptors

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Dehydroepiandrosterone, dehydroepiandrosterone-sulfate, and cortisol concentrations in intensive care unit patients

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Physiological activity and receptor binding of 9 alpha fluorohydrocortisone.

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021

Transactivation via the human glucocorticoid and mineralocorticoid receptor by therapeutically used steroids in CV-1 cells: a comparison of their glucocorticoid and mineralocorticoid properties

1 reference

https://api.crossref.org/works/10.1038/S41398-020-0789-7

7 January 2021